Overview
- Product nameIonotropic Agonists Kit
- SpecificityA collection of 8 agonists, antagonists and potentiators at AMPA, Kainate and NMDA receptors. Products are freeze-dried to an exact weight so that addition of 1 ml or 0.5 ml of solvent provides a stock solution of 5 mM or 10 mM respectively. The kit contains (S)-AMPA, (ab120048).
- Product overview
A collection of 8 agonists, antagonists and potentiators at AMPA, Kainate and NMDA receptors. Products are freeze-dried to an exact weight so that addition of 1 ml or 0.5 ml of solvent provides a stock solution of 5 mM or 10 mM respectively. The kit contains (S)-AMPA, (ab120005), (S)-5-Fluorowillardiine hydrochloride (ab120399), Cyclothiazide (ab120061), Aniracetam (ab120316), Kainic acid (ab120100), (S)-5-Iodowillardiine hydrochloride (ab120401) , NMDA ab120052) and D-serine (ab120048).
Receptor Description AMPA (S)-AMPA:
AMPA agonist.
Suggested Solvent: Water
AMPA (S)-5-Fluorowillardiine hydrochloride:
Potent, selective AMPA receptor agonist. Displays higher affinity than AMPA at hGluR1 and hGlurR2, and displays greater selectivity for AMPA receptor subtypes over the kainate receptor hGluR5.
Suggested Solvent: Water
AMPA Cyclothiazide:
Positive allosteric modulator of AMPA receptors. Produces a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current.
Suggested Solvent: DMSO
AMPA Aniracetam:
Nootropic, positive allosteric modulator of AMPA receptors. Slows AMPA receptor deactivation and desensitisation. Antidepressant and anxiolytic in vivo.
Suggested Solvent: DMSO
Kainate Kainic acid:
Prototypic agonist at the kainate class of ionotropic glutamate receptors. Potent excitant and neurotoxin, used to model epilepsy and neurodegenerative states.
Suggested Solvent: Water
Kainate (S)-5-Iodowillardiine hydrochloride:
Selective GluK1 (formerly GluR5) kainate receptor agonist (EC50 = 83 µM). Partial agonist activity at GluK2 (formerly GluR6/KA2) receptors. Displays low affinity for AMPA and homomeric GluR6 and GluR7 receptors.
Suggested Solvent: DMSO
NMDA NMDA:
Excitotoxic amino acid. Prototypic agonist at the ionotropic NMDA glutamate receptor which is involved in long-term potentiation, ischemia, and epilepsy.
Suggested Solvent: Water
NMDA D-Serine:
Agonist at the NMDA glycine binding site and the inhibitory post-synaptic glycine receptor.
Suggested Solvent: Water
A collection of 8 agonists, antagonists and potentiators at AMPA, Kainate and NMDA receptors. Products are freeze-dried to an exact weight so that addition of 1 ml or 0.5 ml of solvent provides a stock solution of 5 mM or 10 mM respectively. The kit contains (S)-AMPA, (ab120048).
- Notes
KIT
Properties
- Storage instructionsStore at -20°C (desiccating conditions).
-
Components 1 kit ab120399 - (S)-5-Fluorowillardiine hydrochloride 1 vial ab120401 - (S)-5-Iodowillardiine hydrochloride 1 vial ab120005 - (S)-AMPA 1 vial ab120316 - Aniracetam 1 vial ab120061 - Cyclothiazide 1 vial ab120048 - D-Serine 1 vial ab120100 - Kainic acid 1 vial ab120052 - NMDA 1 vial -
Research Areas
modificationsPalmitoylated. Depalmitoylated upon glutamate stimulation. Cys-603 palmitoylation leads to Golgi retention and decreased cell surface expression. In contrast, Cys-829 palmitoylation does not affect cell surface expression but regulates stimulation-dependent endocytosis.
Target information above from: UniProt accession
P42261
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for Ionotropic Agonists Kit (ab120323)
ab120323 has not yet been referenced specifically in any publications.
